149 related articles for article (PubMed ID: 34647172)
1. The emerging PRRX1-NCOA fibroblastic neoplasm: a combined reappraisal of published tumors and two new cases.
Chen CH; Chang KC; Chuang CH; Fu JT; Huang HY
Virchows Arch; 2022 Jul; 481(1):111-116. PubMed ID: 34647172
[TBL] [Abstract][Full Text] [Related]
2. PRRX1-NCOA1-rearranged fibroblastic tumour: a clinicopathological, immunohistochemical and molecular genetic study of six cases of a potentially under-recognised, distinctive mesenchymal tumour.
Dermawan JK; Azzato EM; Jebastin Thangaiah J; Gjorgova-Gjeorgievski S; Rubin BP; Folpe AL; Agaimy A; Fritchie KJ
Histopathology; 2021 Dec; 79(6):997-1003. PubMed ID: 34272753
[TBL] [Abstract][Full Text] [Related]
3. PRRX-NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm.
Lacambra MD; Weinreb I; Demicco EG; Chow C; Sung YS; Swanson D; To KF; Wong KC; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2019 Oct; 58(10):705-712. PubMed ID: 31008539
[TBL] [Abstract][Full Text] [Related]
4. "PRRX1-rearranged mesenchymal tumors": expanding the immunohistochemical profile and molecular spectrum of a recently described entity with the proposed revision of nomenclature.
Warmke LM; Michal M; Martínek P; Agaimy A; Din NU; Perret R; Hostein I; Le Loarer F; Voltaggio L; Gross JM
Virchows Arch; 2023 Aug; 483(2):207-214. PubMed ID: 37338620
[TBL] [Abstract][Full Text] [Related]
5. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
6. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
[TBL] [Abstract][Full Text] [Related]
8. Pigmented PRRX1::NCOA1-rearranged fibroblastic tumor: A rare morphologic variant of an emerging mesenchymal tumor.
Cloutier JM; Maloney NS; Wang WL; Lazar AJ
J Cutan Pathol; 2022 Sep; 49(9):802-807. PubMed ID: 35583270
[TBL] [Abstract][Full Text] [Related]
9. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
10. Low-grade fibromyxoid sarcoma with prominent giant rosettes and heterotopic ossification.
Hisaoka M; Matsuyama A; Aoki T; Sakamoto A; Yokoyama K
Pathol Res Pract; 2012 Sep; 208(9):557-60. PubMed ID: 22819758
[TBL] [Abstract][Full Text] [Related]
11. Sclerosing Epithelioid Fibrosarcoma.
Warmke LM; Yu W; Meis JM
Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
[TBL] [Abstract][Full Text] [Related]
12. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
Mohamed M; Fisher C; Thway K
Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
[TBL] [Abstract][Full Text] [Related]
13. [Low-grade fibromyxoid sarcoma: a clinicopathological analysis of 9 cases].
Lin J; Wang J; Yu LJ; Ying XL
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):302-6. PubMed ID: 19575871
[TBL] [Abstract][Full Text] [Related]
14. Low-grade Fibromyxoid Sarcoma With Massive Degeneration: A Case of Unusual Gross and Histological Features.
Tasaki T; Shiba E; Noguchi H; Kirishima M; Kitazono I; Terabaru W; Tabata K; Higashi M; Shinohara N; Sasaki H; Nakajo M; Nakajo M; Hisaoka M; Tanimoto A
In Vivo; 2023; 37(6):2863-2868. PubMed ID: 37905642
[TBL] [Abstract][Full Text] [Related]
15. Cytomorphologic findings of low-grade fibromyxoid sarcoma.
Mustafa S; VandenBussche CJ; Ali SZ; Siddiqui MT; Wakely PE
J Am Soc Cytopathol; 2020; 9(3):191-201. PubMed ID: 32197967
[TBL] [Abstract][Full Text] [Related]
16. A Sclerosing Perineurioma With Collagen Rosette Formation: Benign Mimic of Low-Grade Fibromyxoid Sarcoma.
Creytens D; Ferdinande L; Van Dorpe J
Int J Surg Pathol; 2018 Apr; 26(2):145-147. PubMed ID: 29172820
[TBL] [Abstract][Full Text] [Related]
17. Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma.
Lane KL; Shannon RJ; Weiss SW
Am J Surg Pathol; 1997 Dec; 21(12):1481-8. PubMed ID: 9414192
[TBL] [Abstract][Full Text] [Related]
18. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
[TBL] [Abstract][Full Text] [Related]
19. Low-grade fibromyxoid sarcoma arising within the median nerve.
Swanson AA; Giannini C; Folpe AL; Van Dyke DL; Amrami KK; Michalak WA; Vaubel RA
Neuropathology; 2018 Jun; 38(3):309-314. PubMed ID: 29314300
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of NCOA2 fluorescence in situ hybridization and Stat6 immunohistochemistry staining for soft tissue angiofibroma and morphologically similar fibrovascular tumors.
Sugita S; Aoyama T; Kondo K; Keira Y; Ogino J; Nakanishi K; Kaya M; Emori M; Tsukahara T; Nakajima H; Takagi M; Hasegawa T
Hum Pathol; 2014 Aug; 45(8):1588-96. PubMed ID: 24856853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
